InstalabLoading...
InstalabLoading...
A breakdown product of the body's main stress hormone that reveals how your liver processes cortisol and whether hidden metabolic stress is building beneath a normal blood test.
Your blood cortisol level can look perfectly normal while your body is quietly overproducing and breaking down cortisol at an accelerated rate. Allo-THF (5-alpha-tetrahydrocortisol) is one of the molecules your liver creates when it processes cortisol, and measuring it in urine captures what a single blood draw can miss: the total throughput of your stress hormone system over time.
Allo-THF belongs to a small family of cortisol breakdown products, collectively called tetrahydro-metabolites. Together with its sibling THF (5-beta-tetrahydrocortisol) and a related molecule called THE (tetrahydrocortisone), these metabolites account for the vast majority of cortisol that leaves your body through urine. One study using high-resolution mass spectrometry found that the glucuronide forms of these three metabolites alone represent over 93% of the cortisol metabolites analyzed.
What makes allo-THF especially informative is not just how much cortisol your body is making, but which enzymatic pathway your liver favors when breaking it down. That distinction can signal metabolic dysfunction, hormonal imbalance, or subtle adrenal overactivity that standard cortisol tests would never flag.
When cortisol arrives at your liver, it can be broken down through two parallel routes. One route uses an enzyme called 5-alpha-reductase, which produces allo-THF. The other uses a different enzyme, 5-beta-reductase, which produces THF. These two enzymes work in separate compartments within the liver, and the balance between them varies from person to person.
After either enzyme does its initial work, a second enzyme (3-alpha-hydroxysteroid dehydrogenase) finishes the job, converting the intermediate product into its final tetrahydro form. The result is a water-soluble molecule your kidneys can filter into urine, where it can be measured.
The ratio between allo-THF and THF in your urine tells you which of these two pathways your liver leans on more heavily. A shift in that ratio can reflect changes in enzyme activity tied to specific clinical conditions.
Clinicians and researchers use allo-THF in two key ratios, each answering a different question about your cortisol metabolism.
The allo-THF to THF ratio tells you about the relative activity of the two liver enzymes that compete to break down cortisol. If your allo-THF is low relative to THF, it suggests your 5-alpha-reductase pathway may be underperforming. This pattern has been observed in people with depression, where significantly lower allo-THF/THF ratios point to a specific disruption in cortisol processing.
The (THF + allo-THF) to THE ratio answers a broader question: how actively is your body converting cortisone back into cortisol? This ratio reflects the activity of a pair of enzymes called 11-beta-hydroxysteroid dehydrogenases (11-beta-HSD1 and 11-beta-HSD2), which act as a switch between cortisol (the active form) and cortisone (the inactive form). A high ratio suggests your body is regenerating more active cortisol from cortisone, or failing to inactivate cortisol efficiently.
If your ratio is elevated, it may be worth investigating whether excess cortisol activity is contributing to blood pressure, blood sugar, or metabolic concerns, even if your standard cortisol blood test looks reassuring.
The total output of cortisol metabolites, measured as the sum of THF, allo-THF, and THE in urine, connects to metabolic health in ways that plasma cortisol alone does not. In one study, increased total urinary glucocorticoid metabolites were associated with metabolic syndrome, insulin resistance, impaired insulin-producing cell function, and low levels of adiponectin (a protective hormone released by fat tissue), all occurring in people whose plasma cortisol appeared normal.
What this means for you: if you have features of metabolic syndrome, such as central weight gain, high blood sugar, or elevated blood pressure, and your routine cortisol test comes back normal, measuring urinary cortisol metabolites including allo-THF may uncover a cortisol processing problem that standard testing would miss.
In people with adrenal incidentalomas (small adrenal gland masses found incidentally on imaging), measuring cortisol metabolites including allo-THF helps distinguish between tumors that are quietly secreting excess cortisol and those that are functionally silent. This metabolite profile outperforms urinary free cortisol alone for making that distinction.
Altered allo-THF/THF ratios have also been observed in polycystic ovary syndrome (PCOS), potentially reflecting changes in 11-beta-HSD enzyme activity. For women with PCOS who are trying to understand the hormonal drivers behind their symptoms, this ratio adds a layer of insight into how cortisol metabolism may be interacting with their broader hormonal picture.
Allo-THF is measured in urine, typically through a 24-hour collection, using a technique called LC-MS/MS (liquid chromatography with tandem mass spectrometry). Modern methods can quantify both the free form and the conjugated (glucuronide-bound) form of allo-THF, THF, and THE simultaneously, giving a comprehensive snapshot of your glucocorticoid metabolism.
Because individual variation in how the liver processes cortisol is well documented, a single measurement is most informative when interpreted alongside the key ratios described above rather than as a standalone number. The interplay between allo-THF, THF, and THE tells a richer story than any one metabolite in isolation.
Certain lab conditions and sample handling factors can occasionally affect results, so confirming abnormal findings with a repeat collection is reasonable before drawing firm conclusions.